To study the
therapeutic effects of a single 40 mg intramuscular dose of
piroxicam versus a single 75 mg intramuscular dose of
diclofenac sodium for treatment of
acute renal colic. - The study comprised 64 patients (52 men and 12 women, mean age 28 years, range 18 - 42) who presented with
acute renal colic and were diagnosed by IVU, a general urine examination and ultrasonography. The patients were randomly assigned to receive either 40 mg of
piroxicam i.m (34 patients) or 75 mg of
diclofenac sodium i.m (330 patients). The severity of
pain was assessed on Visual Analogue Scale. - Results showed that thirty-two patients (94.1%) markedly improved within 1h of receiving
piroxicam and 26 patients (86.6%) improved within 1h of receiving
diclofenac sodium (P <0.05). Within 30 min, 25 patients (73.5%) markedly improved after
piroxicam and 15 patients (50%) markedly improved after
diclofenac sodium (P <0.05). After
piroxicam, none of the patients showed
pain relapse over a period of 24 h while 9 patients had relapse within 24 h after their initial response to
diclofenac sodium. No side effects were reported with use of either treatment. - We concluded that
piroxicam can be used successfully to treat
acute renal colic and it has earlier onset of action and prolong effect as compared with
diclofenac sodium.